
B/m/vinci8/data1/riedel/corpora/nyt/nyt/data/2006/08/15/1782998.xmlÆ

MenNNO

withINO

lowJJO

testosteroneNNO

wereVBDO

muchRBO

moreRBRO

likelyJJO

toTOO

dieVBO

withinINO


aDTO

	specifiedVBNO

timeNNO

frameNNO

thanINO

theirPRP$O

counterpartsNNSO

withINO

normalJJO

levelsNNSO
	
,,O

researchersNNSO

reportedVBDO

	yesterdayNNO
	
..OÆ

LowNNPO

testosteroneNNO

levelsNNSO
	
,,O

commonJJO

inINO

agingVBGO

menNNSO
	
,,O

areVBPO


associatedVBNO

withINO

insulinNNO


resistanceNNO
	
,,O

whichWDTO

canMDO

beVBO


aDTO

	precursorNNO

ofINO

diabetesNNSO

andCCO

otherJJO

seriousJJO

diseasesNNSO
	
..Oû

TheDTO

researchersNNSO

usedVBDO


aDTO

VeteransNNPORGANIZATION

AffairsNNPORGANIZATION

databaseNNO

toTOO

studyVBO

theDTO

medicalJJO

	historiesNNSO

ofINO

858CDO

menNNSO

overINO

ageNNO

40CDO

forINO

fourCDO

yearsNNSO
	
,,O

categorizingVBGO

theirPRP$O

testosteroneNNO

asINO

lowJJO
	
,,O

normalJJO

orCCO

	equivocalJJO
	
,,O

withINO

varyingVBGO

lowJJO

andCCO

normalJJO

testsNNSO
	
..OÇÄÄÄ¯ˇˇˇˇ *ORGANIZATIONÛ

JustRBO

overINO

halfNNO

hadVBDO

normalJJO

levelsNNSO
	
,,O

28CDO

percentNNO

wereVBDO

	equivocalJJO

andCCO

19CDO

percentNNO

lowNNO
	
..OÓ

TheDTO

findingsNNSO

appearVBPO

inINO

TheDTO

ArchivesNNPORGANIZATION

ofINORGANIZATION

InternalNNPORGANIZATION

MedicineNNPORGANIZATION
	
..OÉÄÄÄ¯ˇˇˇˇ *ORGANIZATIONù

MenNNO

withINO

	equivocalJJO

testosteroneNNO

hadVBDO


aDTO

38CDO

percentNNO

greaterJJRO

riskNNO

ofINO

deathNNO

duringINO

theDTO

studyNNO

thanINO

thoseDTO

withINO

normalJJO

testosteroneNNO
	
,,O

andCCO

thoseDTO

withINO

lowJJO

testosteroneNNO

levelsNNSO

hadVBDO

anDTO

88CDO

percentNNO

greaterJJRO

riskNNO
	
..OÈ

TheDTO

correlationsNNSO

heldVBNO

afterINO

controllingVBGO

forINO

ageNNO
	
,,O

medicalJJO

	morbidityNNO
	
,,O

weightNNO

inINO


proportionNNO

toTOO

heightNNO
	
,,O

raceNNO

andCCO

otherJJO

factorsNNSO
	
..O

''''O§

PeopleNNSO

needVBPO

toTOO

lookVBO

atINO

theseDTO

resultsNNSO

veryRBO


cautiouslyRBO
	
,,O

''''O

saidVBDO

Dr.NNPPERSON

MollyNNPPERSON

ShoresNNPPERSON
	
,,O

theDTO

leadJJO

authorNNO

ofINO

theDTO

studyNNO

andCCO

anDTO

	associateJJO

	professorNNO

ofINO


psychiatryNNO

atINO

theDTO


UniversityNNPORGANIZATION

ofINORGANIZATION


WashingtonNNPORGANIZATION
	
..OÖÄÄÄ¯ˇˇˇˇ *PERSONEÑÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000003e520  *ORGANIZATION›


ADTO

majorJJO

concernNNO
	
,,O

Dr.NNPPERSON

ShoresNNPPERSON

saidVBDO
	
,,O

isVBZO

theDTO

useNNO

ofINO

	syntheticJJO

testosteroneNNO
	
,,O

consideringVBGO

theDTO

markedJJO

increaseNNO

inINO

itsPRP$O

useNNO

overINO

theDTO

lastJJO

fiveCDO

yearsNNSO
	
..O

''''OÜÄÄÄ¯ˇˇˇˇ *PERSONñ

ThisDTO

studyNNO
	
,,O

''''O

shePRPO

addedVBDO
	
,,O

''''O

didVBDO

notRBO

examineVBO

theDTO

effectsNNSO

ofINO

testosteroneNNO

	treatmentNNO

onINO

	mortalityNNO
	
,,O

andCCO

youPRPO

caMDO

n'tRBO

concludeVBO

fromINO

thisDTO

thatINO

testosteroneNNO

replacementNNO

willMDO

decreaseVBO

	mortalityNNO
	
..O

''''OR

VITALNNPO

SIGNSNNSO
	
::O

BODYNNPO

	CHEMISTRYNNPO